Table 1 Patient baseline characteristics of NPC patients before PSM
Characteristic | NTZ group N = 50 (%) | Non-NTZ group N = 344 (%) | P value |
|---|---|---|---|
Gender | 0.870 | ||
Male | 34 (68.00) | 240 (69.77) | |
Female | 16 (32.00) | 104 (30.23) | |
Age | 0.387 | ||
≤ 50 | 33 (66.00) | 205 (59.59) | |
> 50 | 17 (34.00) | 139 (40.41) | |
T classification | 0.763 | ||
T1 | 6 (12.00) | 34 (9.88) | |
T2 | 7 (14.00) | 50 (14.53) | |
T3 | 20 (40.00) | 138 (40.17) | |
T4 | 17 (34.00) | 122 (35.47) | |
N classification | 0.855 | ||
N0 | 3 (6.00) | 30 (8.72) | |
N1 | 17 (34.00) | 111 (32.27) | |
N2 | 18 (36.00) | 119 (34.59) | |
N3 | 12 (24.00) | 84 (24.42) | |
Clinical stage | 0.840 | ||
III | 23 (46.00) | 153 (44.48) | |
IV | 27 (54.00) | 191 (55.52) | |